4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-031390
EVP & Chief Tech Ops Officer sold 363 shares at $113.68 ($41,266)
From the SEC's structured data for this filing
Trades in this filing
Huang Dennis Karl · EVP & Chief Tech Ops Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-06 | Sale : show line 1 in the form | −363 | $113.68 | $41,266 | 40,506 | D |
| Open-market sales · 363 sh · avg $113.68 · $41,266 | ||||||
Loading xslF345X03/doc4.xml…